Senior Leadership: This year, Dr. Thompson, an internationally recognized leader in cancer research,replaced Dr. John Click as Director of the Cancer Center. Dr. Thompson appointed Dr. Caryn Lermanto assume his former position as Deputy Director of the Cancer Center and Co-Principal Investigator ofthe Cancer Center Core Grant. Dr. Lerman, the former Associate Director for Cancer Control andPopulation Science, is a scientific leader in cancer control and tobacco related research. In addition,Dr. Lewis Chodosh, a scientific leader in cancer biology, assumed Dr. Thompson's former position asChair of the Cancer Biology Department, and replaced Dr. Mark Greene as the Cancer Center'sAssociate Director for Fundamental Research. With the departure of Dr. Stephen Emerson, Dr. GarrettBrodeur was appointed the Acting Associate Director for Clinical Research; an active search for anAssociate Director for Clinical Research is underway.Drs. Thompson, Lerman, Chodosh and Brodeur form the senior leadership of the Cancer Center. Thisgroup, representing the broad range of expertise in basic science, translational and clinical research,and population science research, is responsible for examining the ongoing initiatives and futuredirections of the Cancer Center at the global level. Drs. Thompson and Lerman meet on a weeklybasis, and the senior leadership group interacts formally on a monthly basis, as well as informallythrough telephone and email. This process ensures timely and proactive decision-making, as well ascohesiveness in direction. The Senior Leadership has been instrumental in reviewing and responding tothe feedback from the competitive Core Grant review process, identifying new leaders for the ExecutiveCommittee and Cancer Center Programs, and reviewing the Core facilities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-33
Application #
7726709
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
33
Fiscal Year
2008
Total Cost
$237,113
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Liu, Wei; Krump, Nathan A; MacDonald, Margo et al. (2018) Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts. J Virol 92:
Schapira, Marilyn M; Barlow, William E; Conant, Emily F et al. (2018) Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol 25:1118-1127
Morrison, Alexander H; Byrne, Katelyn T; Vonderheide, Robert H (2018) Immunotherapy and Prevention of Pancreatic Cancer. Trends Cancer 4:418-428
Yan, Lesan; Amirshaghaghi, Ahmad; Huang, Dennis et al. (2018) Protoporphyrin IX (PpIX)-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters for Magnetic Resonance Imaging and Photodynamic Therapy. Adv Funct Mater 28:
Ojha, Rani; Leli, Nektaria M; Onorati, Angelique et al. (2018) ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma. Cancer Discov :
Han, Joseph; Lachance, Catherine; Ricketts, M Daniel et al. (2018) The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3-H4 substrate. J Biol Chem 293:4498-4509
Waxman, Adam J; Clasen, Suparna; Hwang, Wei-Ting et al. (2018) Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA Oncol 4:e174519
Gangadhar, Tara C; Savitch, Samantha L; Yee, Stephanie S et al. (2018) Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma. Pigment Cell Melanoma Res 31:73-81
Reshef, Ran; Ganetsky, Alex; Acosta, Edward P et al. (2018) Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biol Blood Marrow Transplant :
Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253

Showing the most recent 10 out of 1047 publications